CervoMed Inc. Accounts Payable and Accrued Liabilities
CervoMed Inc. (CRVO) had Accounts Payable and Accrued Liabilities of $2.30 million as of 2013-06-30, per its 10-Q filed 2013-08-14.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2013-08-14
- 2013-06-30: Accounts Payable and Accrued Liabilities $2.30M.
- 2013-03-31: Accounts Payable and Accrued Liabilities $2.01M.
- 2012-12-31: Accounts Payable and Accrued Liabilities $1.68M.
- 2012-09-30: Accounts Payable and Accrued Liabilities $2.58M.
| Period end | Accounts Payable and Accrued Liabilities |
|---|---|
| 2013-06-30 | $2.30M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $2.01M 10-Q/A · filed 2013-05-20 |
| 2012-12-31 | $1.68M 10-Q · filed 2013-08-14 |
| 2012-09-30 | $2.58M 10-Q · filed 2012-11-19 |
| 2012-06-30 | $2.59M 10-Q/A · filed 2012-09-07 |
| 2011-12-31 | $1.54M 10-Q · filed 2012-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |